HEADER GROWTH FACTOR 01-DEC-91 1GMF OBSLTE 08-NOV-96 1GMF 2GMF TITLE NOVEL FOLD AND PUTATIVE RECEPTOR BINDING SITE OF TITLE 2 GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE:; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1 KEYWDS GROWTH FACTOR EXPDTA X-RAY DIFFRACTION AUTHOR P.A.KARPLUS,K.DIEDERICHS REVDAT 1 31-OCT-93 1GMF 0 JRNL AUTH K.DIEDERICHS,T.BOONE,P.A.KARPLUS JRNL TITL NOVEL FOLD AND PUTATIVE RECEPTOR BINDING SITE OF JRNL TITL 2 GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR JRNL REF SCIENCE V. 254 1779 1991 JRNL REFN ASTM SCIEAS US ISSN 0036-8075 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.DIEDERICHS,S.JACQUES,T.BOONE,P.A.KARPLUS REMARK 1 TITL LOW-RESOLUTION STRUCTURE OF RECOMBINANT HUMAN REMARK 1 TITL 2 GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR REMARK 1 REF J.MOL.BIOL. V. 221 55 1991 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 1GMF REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1906 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.017 REMARK 3 BOND ANGLES (DEGREES) : 3.50 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GMF COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 1GMF RESIDUES 1 - 4 AND 124 - 127 ARE NOT SEEN IN THE REMARK 5 ELECTRON 1GMF DENSITY MAP, PROBABLY DUE TO DISORDER. 1GMF REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 1/2-X,-Y,1/2+Z REMARK 290 3555 -X,1/2+Y,1/2-Z REMARK 290 4555 1/2+X,1/2-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.80000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.35000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.55000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.35000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.80000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.55000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 PRO A 2 REMARK 465 ALA A 3 REMARK 465 ARG A 4 REMARK 465 PRO A 124 REMARK 465 VAL A 125 REMARK 465 GLN A 126 REMARK 465 GLU A 127 REMARK 465 ALA B 1 REMARK 465 PRO B 2 REMARK 465 ALA B 3 REMARK 465 ARG B 4 REMARK 465 PRO B 124 REMARK 465 VAL B 125 REMARK 465 GLN B 126 REMARK 465 GLU B 127 SEQRES 1 A 127 ALA PRO ALA ARG SER PRO SER PRO SER THR GLN PRO TRP SEQRES 2 A 127 GLU HIS VAL ASN ALA ILE GLN GLU ALA ARG ARG LEU LEU SEQRES 3 A 127 ASN LEU SER ARG ASP THR ALA ALA GLU MET ASN GLU THR SEQRES 4 A 127 VAL GLU VAL ILE SER GLU MET PHE ASP LEU GLN GLU PRO SEQRES 5 A 127 THR CYS LEU GLN THR ARG LEU GLU LEU TYR LYS GLN GLY SEQRES 6 A 127 LEU ARG GLY SER LEU THR LYS LEU LYS GLY PRO LEU THR SEQRES 7 A 127 MET MET ALA SER HIS TYR LYS GLN HIS CYS PRO PRO THR SEQRES 8 A 127 PRO GLU THR SER CYS ALA THR GLN ILE ILE THR PHE GLU SEQRES 9 A 127 SER PHE LYS GLU ASN LEU LYS ASP PHE LEU LEU VAL ILE SEQRES 10 A 127 PRO PHE ASP CYS TRP GLU PRO VAL GLN GLU SEQRES 1 B 127 ALA PRO ALA ARG SER PRO SER PRO SER THR GLN PRO TRP SEQRES 2 B 127 GLU HIS VAL ASN ALA ILE GLN GLU ALA ARG ARG LEU LEU SEQRES 3 B 127 ASN LEU SER ARG ASP THR ALA ALA GLU MET ASN GLU THR SEQRES 4 B 127 VAL GLU VAL ILE SER GLU MET PHE ASP LEU GLN GLU PRO SEQRES 5 B 127 THR CYS LEU GLN THR ARG LEU GLU LEU TYR LYS GLN GLY SEQRES 6 B 127 LEU ARG GLY SER LEU THR LYS LEU LYS GLY PRO LEU THR SEQRES 7 B 127 MET MET ALA SER HIS TYR LYS GLN HIS CYS PRO PRO THR SEQRES 8 B 127 PRO GLU THR SER CYS ALA THR GLN ILE ILE THR PHE GLU SEQRES 9 B 127 SER PHE LYS GLU ASN LEU LYS ASP PHE LEU LEU VAL ILE SEQRES 10 B 127 PRO PHE ASP CYS TRP GLU PRO VAL GLN GLU FTNOTE 1 ASN 27 AND ASN 37 ARE HETEROGENEOUSLY GLYCOSYLATED IN THE FTNOTE 1 NATURAL PROTEIN. HELIX 1 AA TRP A 13 LEU A 28 1 16 HELIX 2 BA LEU A 55 GLN A 64 1 10 HELIX 3 CA LYS A 74 HIS A 87 1 14 HELIX 4 DA PHE A 103 VAL A 116 1 14 HELIX 5 EA GLY A 68 LEU A 73 5NON-CONSERVED FEATURE OF FOLD 6 HELIX 6 FA ALA A 33 MET A 36 1 4 HELIX 7 AB TRP B 13 LEU B 28 1 16 HELIX 8 BB LEU B 55 GLN B 64 1 10 HELIX 9 CB LYS B 74 HIS B 87 1 14 HELIX 10 DB PHE B 103 VAL B 116 1 14 HELIX 11 EB GLY B 68 LEU B 73 5NON-CONSERVED FEATURE OF FOLD 6 HELIX 12 FB ALA B 33 MET B 36 1 4 SHEET 1 S1 2 THR A 39 ILE A 43 0 SHEET 2 S1 2 THR A 98 THR A 102 -1 SHEET 1 S2 2 THR B 39 ILE B 43 0 SHEET 2 S2 2 THR B 98 THR B 102 -1 SSBOND 1 CYS A 54 CYS A 96 SSBOND 2 CYS A 88 CYS A 121 SSBOND 3 CYS B 54 CYS B 96 SSBOND 4 CYS B 88 CYS B 121 SITE 1 REA 14 GLU A 14 ASN A 17 ALA A 18 GLU A 21 SITE 2 REA 14 ARG A 24 LEU A 25 LYS A 72 LYS A 74 SITE 3 REA 14 GLY A 75 PRO A 76 THR A 78 MET A 79 SITE 4 REA 14 SER A 82 GLN A 86 SITE 1 REB 14 GLU B 14 ASN B 17 ALA B 18 GLU B 21 SITE 2 REB 14 ARG B 24 LEU B 25 LYS B 72 LYS B 74 SITE 3 REB 14 GLY B 75 PRO B 76 THR B 78 MET B 79 SITE 4 REB 14 SER B 82 GLN B 86 CRYST1 47.600 59.100 126.700 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021008 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016920 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007893 0.00000